Information on patients who were first made aware of their severe asthma via shielding letters is not held centrally. However, respiratory disease is a national clinical priority in the NHS Long Term Plan. NHS England and NHS Improvement are working in close partnership with patients and partners, including the British Lung Foundation, and are developing and implementing policy on provisions of respiratory services in England.
NHS England and NHS Improvement’s Accelerated Access Collaborative (AAC) programme supported by the severe asthma toolkit, is increasing treatment adherence, biologic choice, optimising multidisciplinary teams and has been shared widely with the severe asthma clinical community. The AAC programme for severe asthma biologics has increased uptake of asthma drugs including ones covered by the National Institute for Health and Care Excellence’s Technology Appraisals where it has been identified that there is suboptimal uptake.